|Day Low/High||0.40 / 0.44|
|52 Wk Low/High||0.40 / 3.66|
Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria...
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced the dosing of the first patient in its Phase 3 clinical trial of its lead drug candidate eravacycline for the treatment of complicated intra-abdominal ...
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today reported financial results for the quarter ended June 30, 2013.
The company's antibiotic won't have late-stage study data available until 2015 but it's worth the wait.
These under-$10 stocks look poised to trade higher from current levels.
Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) today announced that the U.
The bar for progress has been lowered for biotechs looking to enter the market.
The top 10 open-market insider purchases and sales filed at the SEC Wednesday.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.